High HER2 expression correlates with response to trastuzumab and the combination of trastuzumab and lapatinib in the NeoALTTO phase III trial Meeting Abstract

  

Authors:	Scaltriti, M.; Nuciforo, P.; Bradbury, I.; Sperinde, J.; Serra, V.; Parra, J. L.; Prudkin, L.; Harbeck, N.; Pusztai, L.; Ellis, C.; Eidtmann, H.; Arribas, J.; Piccart, M.; Baselga, J.
Abstract Title:	High HER2 expression correlates with response to trastuzumab and the combination of trastuzumab and lapatinib in the NeoALTTO phase III trial
Meeting Title:	36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	73
Issue:	24 Suppl.
Meeting Dates:	2013 Dec 10-14
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2013-12-15
Language:	English
ACCESSION:	WOS:000209496900213
DOI:	10.1158/0008-5472.sabcs13-p1-08-42
PROVIDER:	wos
Notes:	Meeting Abstract: P1-08-42 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/99229